Press Releases April 12, 2026 08:00 PM

Americold Realty Trust, Inc. Sets Date for First Quarter 2026 Earnings Release and Conference Call

Americold announces Q1 2026 earnings release date and conference call details

By Leila Farooq
Share
Twitter Reddit Facebook LinkedIn
COLD

Americold Realty Trust, Inc., a global leader in temperature-controlled logistics and real estate, announced it will release its first quarter 2026 financial results before market open on May 7, 2026, followed by a conference call at 8 a.m. Eastern Time. The company operates over 230 refrigerated facilities worldwide and serves as a key component of the global food supply chain.

Americold Realty Trust, Inc. Sets Date for First Quarter 2026 Earnings Release and Conference Call
COLD
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Earnings release scheduled for May 7, 2026, with a live webcast and conference call.
  • Americold operates approximately 1.4 billion cubic feet of refrigerated warehouse space across more than 230 facilities globally.
  • The company plays a crucial role in the temperature-controlled logistics sector, connecting producers, processors, distributors, and retailers in the food industry.

ATLANTA, April 13, 2026 (GLOBE NEWSWIRE) -- Americold Realty Trust (NYSE: COLD), a global leader in temperature-controlled logistics, real estate, and value-added services focused on the ownership, operation, acquisition and development of temperature-controlled warehouses, today announced that the Company will release first quarter 2026 financial results before the market opens on Thursday, May 7, 2026. A conference call will be held on Thursday, May 7, 2026 at 8:00 a.m. Eastern Time.

Webcast:

A webcast of the conference call will be available on the Investor Relations section of the Company’s website at www.americold.com. To listen to the live broadcast, go to the site at least 15 minutes prior to the scheduled start time in order to register and install any necessary audio software.

To Participate in the Telephone Conference Call:

Dial in at least 5 minutes prior to start time:
Domestic: 1-877-407-3982
International: 1-201-493-6780

Conference Call Playback:

Domestic: 1-844-512-2921
International: 1-412-317-6671
Pass code: 11161509
The playback can be accessed through May 21, 2026.

About Americold Realty Trust, Inc.

Americold (NYSE: COLD) is a global leader in temperature-controlled logistics and real estate, with a more than 120-year legacy of innovation and reliability. With more than 230 facilities across North America, Europe, Asia-Pacific, and South America – totaling approximately 1.4 billion refrigerated cubic feet – Americold ensures the safe, efficient movement of refrigerated products worldwide.

Our facilities are an integral part of the global food supply chain, connecting producers, processors, distributors, and retailers with tailored, value-added services supported by responsive and reliable supply chains. Leveraging deep industry expertise, smart technology, and sustainable practices, Americold delivers world-class service that creates lasting value for our customers and the communities we serve. Visit www.americold.com to learn more.

Contacts:

Americold Realty Trust, Inc.
Investor Relations
Telephone: 678-459-1959
Email: [email protected] 


Risks

  • Potential uncertainties in global supply chain dynamics impacting refrigerated logistics demand.
  • Market competition and operational risks associated with maintaining and expanding a large global warehouse network.
  • Economic conditions that affect food production, distribution, and retail sectors could influence Americold's financial performance.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026